CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Components of Revenue:
Revenue, net	$ 65,896	$ 65,865
Costs and Expenses:
Cost of revenues	42,373	43,480
Selling, general and administrative expenses	20,785	23,408
Product development and research expenses	10,758	14,076
Total costs and expenses	73,916	80,964
Operating loss	(8,020)	(15,099)
Other Expense:
Foreign currency exchange loss	(1,523)	(3,371)
Debt partial extinguishment of 2019 Notes	(185)	(4,235)
Debt extinguishment of Prior Term Loan	0	(1,315)
Interest and other expense, net	(21,154)	(12,298)
Change in the fair value of derivative liability	6,769	0
Loss on debt restructuring	(920)	0
Loss before income tax expense	(25,033)	(36,318)
Income tax expense / (benefit)	91	(62)
Net loss attributable to common stockholders	$ (25,124)	$ (36,256)
Basic and diluted loss per share (in dollars per share)	$ (0.47)	$ (0.68)
Weighted average shares of common stock outstanding:
Basic and diluted (in shares)	53,839,139	53,592,930